Venezuela Humanitarian Aid Import: Where the Boundary to Commercial Sale Lies

1. Key takeaways

Venezuela has non-commercial channels including humanitarian aid, and the Office of Foreign Assets Control (OFAC) of the US Department of the Treasury also authorizes the export of medical devices to Venezuela under General License 4C. But the boundary must be stated precisely: the humanitarian channel does not constitute a commercial sales license, and GL 4C authorizes the act of export rather than the act of sale.

The conclusion has three layers. First, products entering through the humanitarian channel must not be diverted to commercial sale. Second, GL 4C answers whether an export may take place, not whether payment may be received. Third, the compliance obligations of the two channels are independent of each other, and satisfying one does not discharge the other.

These distinctions matter because the two regimes use similar language for different purposes. Both speak of humanitarian use, both exempt defined transactions, and neither converts an exempt transaction into a permanent product status. A manufacturer that treats either channel as a market entry route is relying on a permission that was never granted, and the exposure is legal rather than commercial.

2. Legal basis

Jurisdiction note: GL 4C and 31 CFR Part 591 are US rules with extraterritorial reach. Their application to a manufacturer in the Chinese mainland depends on whether that party constitutes a US person or whether a US nexus exists, for example settlement in US dollars, US-origin content or a US intermediary. Whether they apply must be determined case by case and does not constitute a general conclusion.

3. Expert insights

Insight 1: the definitional provision in GL 4C deserves to be read word by word. The definition of medical device in GL 4C refers directly to section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). This means its scope is set by US law and may not coincide fully with Venezuela’s own definition of a device. A device within Venezuelan regulatory scope does not necessarily fall within the GL 4C authorization, and the converse is equally true. A product that is authorized for export under one definition may still be unregistrable under the other.

Insight 2: the use limitation in the humanitarian exemption mirrors Venezuela’s own exemption regime. Venezuela’s domestic registration exemption is directed at non-sale purposes (see Article 14), and the exemption under the US sanctions framework is likewise directed at humanitarian use. Two rules from different legal orders share the same logic at this point: what is exempted is a specific act for a specific purpose, not a permanent qualification of the product.

Insight 3: the existence of informal channels is a prominent feature of the Venezuelan market, but it should not become a compliance strategy. Industry sources indicate that the formal supply chain in Venezuela is disrupted and that some products enter through unconventional channels. The pharmaceutical industry association has publicly noted the presence of imported medicines that hold no Venezuelan sanitary registration and carry only the registration of the country of origin. For a manufacturer, such channels deliver uncontrolled legal and reputational risk and should not form part of a market entry plan.

A practical test for any proposed arrangement is whether the counterparty can produce the legal basis in writing, with a reference number. Proposals described as a special channel, a well-established practice or a matter of local relationships usually cannot, and the absence of a citable basis is itself the answer.

The same discipline applies internally. Where a shipment is made under a humanitarian authorization, the commercial team should not be able to allocate those units to a distributor account, and the restriction should be enforced by the order management system rather than by a note in an email. Controls that depend on individuals remembering a rule tend to be the ones that fail first when a large order arrives.

Documentation of end use is the other control that has to be designed in advance. Recording the receiving institution, the quantity delivered and the date of delivery allows a manufacturer to demonstrate, months later, that a specific consignment went to a specific destination. Without that record, the answer to a question about where a shipment ended up is a matter of recollection, and recollection is not evidence.

4. Practical recommendations

1. Route every commercial sales project through the full registration path and do not rely on the humanitarian channel or GL 4C as a substitute for it.
2. Where the humanitarian channel is genuinely required, define the use precisely and record the final destination, so that diversion into commercial sale can be shown not to have occurred.
3. For projects involving a US nexus — US dollar settlement, US-origin content or a US intermediary — complete sanctions compliance screening before shipment, including counterparty screening and look-through checks under the 50 percent rule (see Article 40).
4. Where a partner proposes a special channel, require written legal grounds and a reference number, and decline the proposal if these cannot be provided.

5. Verification checklist

• □ The project is clearly classified as commercial sale or humanitarian use, with no mixing of the two
• □ Humanitarian use projects record the final destination and have not been diverted to commercial sale
• □ The US nexus assessment and sanctions compliance screening have been completed where applicable
• □ The scope of GL 4C has been checked item by item against the definition it incorporates from 21 U.S.C. 321
• □ Any special channel proposed by a partner is supported by written legal grounds on file

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Venezuela for manufacturers, importers and authorized representatives, covering the separation of commercial and humanitarian routes, sanctions screening coordination and documentation of end use. For scope and document requirements, contact info@grzanglobal.com.